People: Cempra Inc (CEMP.O)

CEMP.O on Nasdaq

31 Jul 2014
Price Change (% chg)

$-0.44 (-4.56%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Johnson, John 

Brief Biography

Mr. John H. Johnson is an Independent Director of Cempra, Inc. He has served as the Chief Executive Officer and as a director of Savient Pharmaceuticals, Inc. since 2011. Mr. Johnson was Senior Vice President of Eli Lilly and Company and President of Lilly Oncology, Eli Lilly’s oncology business unit, from 2009 to 2011. From 2007 to 2009, Mr. Johnson was Chief Executive Officer of ImClone Systems Incorporated and was also a member of ImClone’s board of directors until it became a wholly-owned subsidiary of Eli Lilly in 2008. From 2001 to 2007, Mr. Johnson served as company group chairman of Johnson & Johnson’s Worldwide Biopharmaceuticals unit. Mr. Johnson holds a B.S. in Education from East Stroudsburg University of Pennsylvania.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks